NCT01219088.
Trial name or title | Postoperative pain control among intrathecal 0.1 mg morphine, femoral nerve block or periarticular infiltration of 20 mL of 0.25% bupivacaine in patients post intramedullary hip screw |
Methods | Parallel RCT Single‐blind (outcome assessor) |
Participants | Inclusion criteria: 18‐90 years old, good consciousness, well co‐operated, can use patient‐controlled analgesia machine, ASA physical status I‐III, no contraindication for spinal anaesthesia, accept spinal anaesthesia, body weight > 30 kg, body mass index 20‐35 kg/m2, no history of research drug allergy Exclusion criteria: previous history of hip surgery (the same side), pathological fracture, severe infection or bone cancer |
Interventions |
Treatment group 1: femoral nerve block, spinal anaesthesia plus femoral nerve block with 20 mL of 0.25% bupivacaine Treatment group 2: periarticular bupivacaine infiltration, spinal anaesthesia plus periarticular infiltration with 20 mL of 0.25% bupivacaine Control group 1: spinal anaesthesia with 0.5% bupivacaine alone Control group 2: spinal anaesthesia plus 0.1 mg of intrathecal morphine |
Outcomes | Primary outcome measures: amount of morphine consumed during first 24 hours after surgery Secondary outcome measures: efficacy of pain control, patient satisfaction, incidences of adverse events (nausea, vomiting, pruritus) |
Starting date | September 2010 |
Contact information | Thitima Chinachoti, MD (Madihol University), Faculty of Medicine Siniraj Hospital, Bangok, Thailand, 10700 |
Notes |